SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-029555
Filing Date
2022-08-15
Accepted
2022-08-15 07:51:42
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10040257_10q.htm   iXBRL 10-Q 981682
2 EXHIBIT 31.1 brhc10040257_ex31-1.htm EX-31.1 11558
3 EXHIBIT 31.2 brhc10040257_ex31-2.htm EX-32.2 11580
4 EXHIBIT 32.1 brhc10040257_ex32-1.htm EX-32.1 5458
5 EXHIBIT 32.2 brhc10040257_ex32-2.htm EX-32.2 5489
  Complete submission text file 0001140361-22-029555.txt   4990995

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20220630.xsd EX-101.SCH 38681
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20220630_cal.xml EX-101.CAL 33531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20220630_def.xml EX-101.DEF 206590
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20220630_lab.xml EX-101.LAB 532431
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20220630_pre.xml EX-101.PRE 336521
52 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040257_10q_htm.xml XML 653205
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 221162386
SIC: 2834 Pharmaceutical Preparations